Showing results (2421-2430 of 3,767) with videos related to
Sort By:
Pageof 377
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Loss of WT1 expression in the endometrium of infertile PCOS patients: a hyperandrogenic effect?D Gonzalez, H Thackeray, P D Lewis, et al.Surgical Infections|July 20, 2011
Reducing the risk of surgical site infections: did we really think SCIP was going to lead us to the promised land?Charles E Edmiston, Maureen Spencer, Brian D Lewis, et al.Cancer Chemotherapy and Pharmacology|November 8, 2011
The effect of food on the bioavailability of panobinostat, an orally active pan-histone deacetylase inhibitor, in patients with advanced cancerGeoffrey I Shapiro, Richard Frank, Uday B Dandamudi, et al.The Journal of Rheumatology|April 1, 1993
Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practiceR Buchbinder, S Hall, P N Sambrook, et al.Journal of Vascular Surgery|December 3, 2014
The effect of Surgical Care Improvement Project measures on national trends on surgical site infections in open vascular proceduresAnahita Dua, Sapan S Desai, Gary R Seabrook, et al.Pharmacoepidemiology and Drug Safety|April 30, 2024
Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritisKyoko Saito, Avinash Gabbeta, Evan Mulvihill, et al.Journal of Neuroimmunology|June 5, 2002
Ganglioside reactive antibodies in the neuropathy associated with celiac diseaseArmin Alaedini, Peter H R Green, Howard W Sander, et al.Plos Neglected Tropical Diseases|April 17, 2012
Multiple mitochondrial introgression events and heteroplasmy in trypanosoma cruzi revealed by maxicircle MLST and next generation sequencingLouisa A Messenger, Martin S Llewellyn, Tapan Bhattacharyya, et al.Cancer Chemotherapy and Pharmacology|June 18, 2010
Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancerUday B Dandamudi, Laurel M Adams, Brendan Johnson, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 28, 2009
Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendationsJames D Lewis, Oren Abramson, Monina Pascua, et al.Pageof 377